Medical pot activists fear epilepsy drug could undercut them
COLUMBUS, Ohio - An experimental epilepsy drug made from cannabis plants grown in England is complicating the medical marijuana debate in hospitals and statehouses.
Epidiolex is a nearly pure extract of cannabidiol, or CBD, with little of the tetrahydrocannabinol, or THC, that gets users high.
CBD products are the current rage in medical marijuana movement, and activists fear Food and Drug Administration approval of Epidiolex could undercut their political momentum and access to the whole plant.
Anup Patel, a pediatric neurologist at Columbus' Nationwide Children's Hospital, insists Epidiolex contains the optimal known marijuana compound for treating seizures. It will be submitted for FDA approval later this year.
So far, the FDA has not found any botanical form of marijuana to be safe or effective to treat any disease or condition.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Lace up your sneakers: Runners prepare for Louisiana Marathon weekend
Downtown library officials: no progress in nine months
Friends, family mourn Brookshire Ave. shooting victim
Insurance won't cover man's $20k hospital bill due to policy terminology
State issues administrative order demanding repairs for Clinton water system